Shivatra Noi Talchai
Current Appointment: Principal Investigator, King Mongkut's University of Technology Thonburi, Thailand Dr. Talchai received her PhD in Human Nutrition from Columbia University. She is the recipient...
65 Results
Clear Filters
NYSCF Outreach
The 2014 NYSCF Spring Outreach Panel on Stem Cell Research and Alzheimer's and Parkinson's Disease The New York Stem Cell Foundation hosts a slate of on-going...
An Interview with Kevin Eggan on his Work in Reprogramming and Induced Pluripotent Stem Cells
Our first post is an interview with Dr. Kevin Eggan, NYSCF’s Chief Scientific Officer and an Associate Professor in the Department of Stem Cell and Regenerative...
The Wall Street Journal – Hedge-Fund Founder Bolsters Stem-Cell Research With $27 Million Gift
Advocates of stem-cell research say they were long waiting for someone like Julian Robertson, who founded one of the earliest hedge funds in Tiger Management Corp....
Interview with NYSCF-Druckenmiller Fellow, Daylon James
NYSCF-Druckenmiler Fellow, Dr. Daylon James, had his research on endothelial differentiation and expansion published in Nature Biotechnology on January 17th. In this interview, Dr. James talks...
Discovery of Genetic Toggle Switch Moves Science Closer to Possible Diabetes Cure
“Scientists have identified a master regulator gene for early embryonic development of the pancreas and other organs, putting researchers closer to coaxing stem cells into pancreatic...
Diabetes stem-cell treatment looks to cell capsules
Nature Reports “Finding the right way to protect cells, and intellectual property, will be key for getting cell therapy to patients.”Read More »
NYSCF Receives Grant for Diabetes Research from Helmsley Foundation
The New York Stem Cell Foundation has received a grant from the Leona M. and Harry B. Helmsley Foundation to provide seed funding for the initial...
Dr. Kevin Eggan and Dr. Doug Melton Recognized in TIME Magazine
NYSCF-supported research by Dr. Kevin Eggan was named as Time Magazine’s top medical breakthrough of 2008.
Stem Cell Therapy Controls Diabetes in Mice
The New York Times “Scientists reported on Wednesday that they were able to control diabetes in mice by harnessing human embryonic stem cells. The work...
San Diego Company’s Stem Cells Treat Diabetes in Mice
The San Diego Union-Tribune “A tiny San Diego biotechnology company has coaxed human embryonic stem cells to evolve into cells that produce insulin to control blood...
The Stem Cell Wars Are Not Over
First appeared in The Huffington Post Nothing would give the millions of people afflicted with heart disease, diabetes, cancer, Parkinson’s disease, Alzheimer’s disease and spinal cord...
NYSCF Responds to New Jersey Stem Cell Vote
The New York Stem Cell Foundation expresses its disappointment in the state of New Jersey for voting “no” on the Stem Cell Research Bond Act ballot...
After Bush’s Veto, What is Next for Stem Cell Research?
First appeared in The Huffington Post For the second consecutive year, President Bush is vetoing legislation that would expand the range of human embryonic stem cell...
NYSCF Playing Critical Role in New Effort to Create Diabetes-Specific Stem Cell Lines
View press release »